Center for Biomedical Modeling, Semel Institute of Neuroscience & Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90024, USA.
Science. 2010 Feb 5;327(5966):697-701. doi: 10.1126/science.1180556. Epub 2010 Jan 14.
Over the past two decades, HIV resistance to antiretroviral drugs (ARVs) has risen to high levels in the wealthier countries of the world, which are able to afford widespread treatment. We have gained insights into the evolution and transmission dynamics of ARV resistance by designing a biologically complex multistrain network model. With this model, we traced the evolutionary history of ARV resistance in San Francisco and predict its future dynamics. By using classification and regression trees, we identified the key immunologic, virologic, and treatment factors that increase ARV resistance. Our modeling shows that 60% of the currently circulating ARV-resistant strains in San Francisco are capable of causing self-sustaining epidemics, because each individual infected with one of these strains can cause, on average, more than one new resistant infection. It is possible that a new wave of ARV-resistant strains that pose a substantial threat to global public health is emerging.
在过去的二十年中,在有能力负担广泛治疗的世界上较富裕国家,艾滋病毒对抗逆转录病毒药物(ARV)的耐药性已经上升到很高的水平。我们通过设计一个生物上复杂的多株网络模型,深入了解了 ARV 耐药性的演变和传播动态。利用这个模型,我们追踪了旧金山 ARV 耐药性的进化历史,并预测了其未来的动态。通过分类和回归树,我们确定了增加 ARV 耐药性的关键免疫、病毒学和治疗因素。我们的模型表明,目前在旧金山流行的 60%的 ARV 耐药株能够引起自我维持的流行,因为每个感染这些菌株之一的个体平均可以引起超过一次新的耐药感染。有可能出现一波对全球公共卫生构成重大威胁的新的 ARV 耐药株。